Ad is loading...
FGHMX
Price
$103.37
Change
-$1.97 (-1.87%)
Updated
Nov 15 closing price
FGJMX
Price
$109.35
Change
-$2.08 (-1.87%)
Updated
Nov 15 closing price
Ad is loading...

FGHMX vs FGJMX

Header iconFGHMX vs FGJMX Comparison
Open Charts FGHMX vs FGJMXBanner chart's image
Fidelity Advisor Communication ServicesC
Price$103.37
Change-$1.97 (-1.87%)
VolumeN/A
CapitalizationN/A
Fidelity Advisor Communication ServicesI
Price$109.35
Change-$2.08 (-1.87%)
VolumeN/A
CapitalizationN/A
FGHMX vs FGJMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGHMX vs. FGJMX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHMX is a Hold and FGJMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FGHMX (1.65B) and FGJMX (1.65B) have equal amount of cash in the bank . FGHMX (0.00) and FGJMX (0.00) have matching dividends . FGHMX was incepted earlier than FGJMX: FGHMX (6 years) vs FGJMX (6 years). FGHMX (45.00) and FGJMX (45.00) have comparable annual turnover. FGHMX (0) and FGJMX (0) have matching initial minimum investment requirements. FGJMX (31.23) and FGHMX (29.73) have marching annual gain over last year. FGJMX return over 5 years is better than : 66.41 vs. FGHMX (58.98).
FGHMXFGJMXFGHMX / FGJMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years6 years-
Gain YTD23.19224.45995%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B1.65B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year29.7331.2395%
Returns for 3 years9.2212.8172%
Returns for 5 years58.9866.4189%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYK390.086.80
+1.77%
Stryker Corp
CAE21.75-0.24
-1.09%
CAE
ADTN7.75-0.22
-2.76%
ADTRAN Holdings
NUTX28.70-2.63
-8.39%
Nutex Health Inc.
RXRX6.18-0.74
-10.64%
Recursion Pharmaceuticals